The Comparison of clinical and side effects of Cinnaferon with Betaferon in patients with Relapsing- Remitting Multiple Sclerosis.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- Sponsors CinnaGen
- 21 Dec 2012 Recruitment complete, according to the Iranian Registry of Clinical Trials.
- 13 Nov 2012 New trial record